Patterns of drug resistance in pulmonary tuberculosis cases in the Izmir district, Turkey.

Antituberculosis drug resistance patterns were investigated among the new and previously treated pulmonary tuberculosis (TB) cases in Izmir district, retrospectively. Proportions of resistance patterns were determined using a number of resistant cases using as a denominator. Resistance to at least one drug was found in 304 (29.7%) patients in 1023 a total of tuberculosis cases. 182 new and 82 previously treated consecutive pulmonary tuberculosis cases were investigated. Patterns were examined as single and/or probable combinations of isoniazid (H), rifampicin (R), ethambutol (E) and streptomycin (S). Single drug resistance mode, mono S, and HS resistance patterns were the highest proportions in comparison with other modes and patterns in both new and previously treated cases. HRS pattern showed a significant proportion and proportions of quadruple mode were higher than triple mode in previously treated cases. Proportions of patterns associated with R were detected more than expected. Surveillance of proportions of anti-TB drug resistance is important as well as surveillance of resistance rates.

[1]  O. Karabay,et al.  Antituberculosis drug resistance and associated risk factors in the European section of Turkey. , 2004, The Indian journal of chest diseases & allied sciences.

[2]  V. Avkan Oğuz,et al.  [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey]. , 2004, Mikrobiyoloji bulteni.

[3]  R. Loddenkemper,et al.  Strategies against multidrug-resistant tuberculosis , 2002, European Respiratory Journal.

[4]  E. AUGUSTYNOWICZ-KOPEĆ,et al.  Primary and acquired drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  F. Drobniewski,et al.  Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. , 2000, The European respiratory journal.

[6]  D. Wilkinson.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[7]  Mohammad Mustafizur Rahman,et al.  Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  A G Leitch,et al.  Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. , 1996, The European respiratory journal.

[9]  T. Yamada,et al.  [Drug resistance in Mycobacteria (author's transl)]. , 1976, Kekkaku : [Tuberculosis].

[10]  P. Escalante.  Tuberculosis , 1904, Annals of Internal Medicine.

[11]  D. Karnak,et al.  Mycobacterium tuberculosis drug resistance in Turkey, 1976-97. , 2000, Scandinavian journal of infectious diseases.

[12]  C. Dye,et al.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[13]  D. Mitchison.  Drug resistance in mycobacteria. , 1984, British medical bulletin.

[14]  A. Khomenko,et al.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. , 1969, Bulletin of the World Health Organization.